Received: 3 November 2020
Accepted: 30 November 2020
First Online: 9 December 2020
Consent for publication
: We obtained the patient’s written consent for publication.
: Maike F. Dohrn has received scientific funding from Pfizer (ASPIRE 2018), has served as a paid consultant for Amicus, Akcea, Alnylam, and Pfizer, and is currently receiving a scholarship for a research fellowship by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG). Jörg B. Schulz serves at advisory boards for Biogen and Roche. Burkhard Gess received financial support from Pfizer, Grifols, and Bayer for conference contributions. Simone Tauber has participated in paid scientific advisory boards by Roche and received financial travelling support and consultant honoraries by Novartis, Tena, Merck, Roche, and Biogen. All of the aforementioned conflicts are not related to the content of the manuscript. US, CK, and DC have no conflicts to disclose. All authors read and approved the manuscript.